Subscribe To
Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Initial Clinical Data Readout from Ongoing Phase 1/2 Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Anticipated by End of 2023 Received $5 Million Research and Development Collaboration Milestone Payment from Merck Cash Runway into early 2025 SEATTLE, Aug. 11, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the […] The post Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update appeared first on ForexTV...
Read More
Posted: Aug 11 2023, 20:01
Author Name: forextv
Views: 101993